Cheng Xu

1.5k total citations
99 papers, 1.1k citations indexed

About

Cheng Xu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Cheng Xu has authored 99 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cancer Research, 24 papers in Pulmonary and Respiratory Medicine and 24 papers in Oncology. Recurrent topics in Cheng Xu's work include Breast Cancer Treatment Studies (24 papers), Breast Lesions and Carcinomas (12 papers) and Advanced Radiotherapy Techniques (9 papers). Cheng Xu is often cited by papers focused on Breast Cancer Treatment Studies (24 papers), Breast Lesions and Carcinomas (12 papers) and Advanced Radiotherapy Techniques (9 papers). Cheng Xu collaborates with scholars based in China, United States and France. Cheng Xu's co-authors include Jiayi Chen, Lu Cao, Xiaoyan Lin, Duan Ma, Wei‐Xiang Qi, Fengyun Zheng, Yating Chen, Gang Cai, Hongwei Zhang and Fengfeng Cai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Cheng Xu

87 papers receiving 1.1k citations

Peers

Countries citing papers authored by Cheng Xu

Since Specialization

Citations

This map shows the geographic impact of Cheng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Xu more than expected).

Fields of papers citing papers by Cheng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Xu. The network helps show where Cheng Xu may publish in the future.

Co-authorship network of co-authors of Cheng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Xu. A scholar is included among the top collaborators of Cheng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Xu. Cheng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	One-week regimen for postoperative regional irradiation in breast cancer: the ARROW trial protocol 2025 ·BMJ Open ·(unknown), (unknown), Wei‐Xiang Qi, Lu Gan, (unknown), Juan Jiang, Jie Zhang, Yonggang Shi, Meilian Dong, Gang Cai, Rong Cai, Cheng Xu, Haoping Xu, (unknown), (unknown), Mei Chen, Lu Cao, (unknown)	0
2	Genetically platform presenting CD24 ScFv enhance antitumor immunity by restoring macrophage phagocytosis and modulating the immune environment 2025 ·Cell Communication and Signaling ·Guannan Zhou, Yuanyuan Gu, Menglei Zhang, Hang Zhou, Yao Li, Xiaoyan Lin, Guanming Lu, (unknown), Cheng Xu, Keqin Hua, Jingxin Ding	0
3	Cytochrome P450 F3 promotes colorectal cancer via inhibiting NRF2-mediated ferroptosis 2024 ·Translational Oncology ·(unknown), Cheng Xu, Jie Lu, Chenfeng He, Xinyue Wang, (unknown), Aizhong Wang, Zhengyun Zhang, Can Jiang	3
4	A randomized trial of early cardiotoxicity in breast cancer patients receiving postoperative IMRT with or without serial cardiac dose constraints 2024 ·International Journal of Cancer ·Lu Cao, (unknown), Wei‐Xiang Qi, Cheng Xu, Ming Ye, (unknown), Mei Shi, (unknown), (unknown), Tong Liu, Gang Cai, Rong Cai, Mei Chen, Yibin Zhang, (unknown), (unknown), (unknown), Jiayi Chen	1
5	Racial and social-economic inequalities in systemic chemotherapy use among adult glioblastoma patients following surgery and radiotherapy 2024 ·Scientific Reports ·Fei Xu, Hua Xin, (unknown), Weiguo Cao, (unknown), Cheng Xu, Jiayi Chen, Gao Yun-sheng, (unknown), (unknown)	2
6	Impact of multidisciplinary team on the pattern of care for brain metastasis from breast cancer 2023 ·Frontiers in Oncology ·Fei Xu, (unknown), Wei‐Xiang Qi, (unknown), Yiming Han, Gang Cai, Lu Cao, Cheng Xu, Jiayi Chen	0
7	The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients 2023 ·The Breast ·(unknown), Chuying Chen, Wei‐Xiang Qi, Gang Cai, Cheng Xu, Rong Cai, (unknown), Kunwei Shen, Lu Cao, Jiayi Chen	9
8	Ki-67 Index Provides Long-Term Survival Information for Early-Stage HER2-Low-Positive Breast Cancer: A Single-Institute Retrospective Analysis 2022 ·Journal of Oncology ·Wei‐Xiang Qi, (unknown), Lu Cao, Cheng Xu, Gang Cai, Jiayi Chen	4
9	Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy 2022 ·Journal of Oncology ·(unknown), (unknown), Gang Cai, Cheng Xu, Rong Cai, Min Li, Kunwei Shen, Xiaosong Chen, (unknown), (unknown), Lu Cao, Jiayi Chen	0
10	Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy 2022 ·Frontiers in Oncology ·(unknown), Lu Cao, Cheng Xu, Gang Cai, (unknown), Wei‐Xiang Qi, Jiayi Chen	5
11	Simultaneous integrated boost for mediastinal lymph node recurrence after radical surgery for esophageal cancer: Interim results from a phase I/II prospective study 2021 ·Thoracic Cancer ·(unknown), (unknown), Lu Cao, Cheng Xu, Shengguang Zhao, Jiayi Chen	2
12	Lumpectomy Combined with Adjuvant Radiotherapy Could Be a Treatment Option for Primary Squamous Cell Carcinoma of the Breast 2021 ·Journal of Oncology ·Wei‐Xiang Qi, Lu Cao, Cheng Xu, Jiayi Chen	2
13	Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials 2020 ·ESMO Open ·Jian‐Guo Zhou, Lang Huang, Su‐Han Jin, Cheng Xu, Benjamin Frey, (unknown), Udo S. Gaipl	22
14	Radiological features of non-small-cell lung cancer with brain metastases in a single center: an implication for the HA-WBRT approach 2018 ·Zhonghua fangshe zhongliuxue zazhi ·(unknown), Weimin Chai, Cheng Xu, Lu Cao, (unknown), Gang Cai, Jiayi Chen	2
15	Retroperitoneoscopic Partial Nephrectomy for Moderately Complex Ventral Hilar Tumors: Surgical Technique and Trifecta Outcomes from a Single Institution in China 2016 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Longfei Liu, Lin Qi, Yangle Li, Minfeng Chen, Chao Li, Cheng Xu, Peihua Liu, Xiongbing Zu	6
16	Resting state functional magnetic resonance imaging in patients with first-episode major depression disorder 2014 ·Zhonghua xingwei yixue yu naokexue zazhi ·Bing Zhao, (unknown), Liying Hou, Cheng Xu	1
17	Does pure robotic partial nephrectomy provide similar perioperative outcomes when compared to the combined laparoscopic–robotic approach? 2013 ·Journal of Robotic Surgery ·Andrew Harbin, Gaurav Bandi, Anup Vora, Cheng Xu, (unknown), Kevin McGeagh, (unknown), (unknown), John H. Lynch, (unknown), (unknown), (unknown)	2
18	Prognostic significance of mammalian sterile 20-like kinase 1 in breast cancer 2013 ·Tumor Biology ·Xiaoyan Lin, Fengfeng Cai, Xiaoyan Li, Xiaoli Kong, Cheng Xu, (unknown), Qifeng Yang	21
19	The Assess Index System and Evaluation Model of Water-Saving Agricultural Benefits in Hilly Area,Sichuan 2007 ·Journal of Mountain Science ·Cheng Xu	0
20	A New Ferroelectric Capacitor Model and Its Application in 1T/1C FeRAM 2004 ·Cheng Xu	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact